Unverified90% confidenceDecision RuleTime unknown
孕期及哺乳期补充首选DHA含量≥200mg/粒且EPA极低或不含的藻油，因EPA有抗凝血倾向而孕期核心需求是胎儿脑视网膜发育的DHA
1
Sources
90%
Confidence
Long-term
Relevance
-
First Seen
Sources
Related Entities
Related Claims
Unverified以降甘油三酯/心血管为目标时优先EPA占比高的产品（EPA:DHA约2:1以上），以孕期/婴幼儿脑视力发育为目标时优先DHA占比高的产品（DHA:EPA约4:1或纯DHA藻油）87% similarUnverified偏重抗炎/心血管选EPA为主（EPA:DHA约2:1或更高）；偏重脑部/眼睛/孕期发育选DHA为主，孕妇优先DHA≥200mg/日的配方87% similarUnverified孕妇及婴幼儿优先选高DHA低EPA配方（DHA:EPA≥4:1或纯DHA藻油），EPA有轻微抗凝血作用且孕期需求以DHA为主87% similarUnverified按目标选EPA/DHA比例：偏重心血管与抗炎选高EPA配方（EPA:DHA约2:1或以上）；孕期哺乳期及婴幼儿脑视力发育选高DHA配方；藻油天然以DHA为主，EPA含量低87% similarUnverified孕期首选高DHA低EPA配比，DHA:EPA≥4:1或选择纯DHA藻油配方，因EPA有抗凝血作用过量可能影响孕晚期止血与胎盘功能86% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/445232API
curl https://kongchang.com/api/v1/knowledge/claims/445232MCP
get_claim(id=445232)